Redfield, Robert R. (CDC/OD) FO) GF

Cc: Cochran, Norris (HHS/ASFR)——— Cabezas, Miriam (HHS/ASFR)
CS SSSCSC >; Hittle, Taylor (HHS/ASFR) FO)

Subject: RE: Close Hold Review - Send comments by 1:40 pm

 

Jen:

See my suggested edits in red.
Thanks,
Tony

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone

FAX: (307) 47964409

 

The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. It should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on

behalf of the NIAID by one of its representatives.

From: Moughalian, Jen (HHS/ASFR) <<  G

Sent: Monday, February 24, 2020 1:18 PM
To: McGowan, Robert (Kyle) (CDC/OD/OCS) (©) >; Shuy, Bryan (OS/ASPR/IO)
CO G>; Kadlec, Robert (OS/ASPR/IO)fL OG } Grigsby, Garrett
(HHS/OS/OGA) Ny Ol>; Zebley, Kyle (HHS/OS/OGA) < Ey Ol>;
Anthony (NIH/NIAID) EL 0»; Lenihan, Keagan (FDA/OC)

>; Redfield, Robert R. (CDC/OD) Fy GJ

Ce: Cochran, Norris (HHS/ASFR) ne (1 © 5 Cabezas, Miriam (HHS/ASFR)

>; Hittle, Taylor (HHS/ASFR) [>

Subject: Close Hold Review - Send comments by 1:40 pm

   

Importance: High

Close hold. Please see below draft OMB language for a possible emergency supplemental request. Due
to the fast moving nature of this process, please send comments by 1:40 PM. Numbers are still under

discussion, and we will share more info in the daily update.

NIH-001440
